PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: 919 Marketing

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation - Cornerstone BioPharma of Cary, NC, and J-Med Pharmaceuticals of Boston, Ma, announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd of Ft Worth, TX, in connection with US Patent No. 6,270,796 & AlleRx™ Dose Pack
Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation

 

NewswireToday - /newswire/ - Holly Springs, NC, United States, 2007/01/19 - Cornerstone BioPharma of Cary, NC, and J-Med Pharmaceuticals of Boston, Ma, announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd of Ft Worth, TX, in connection with US Patent No. 6,270,796 & AlleRx™ Dose Pack.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cornerstone BioPharma, J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation Concerning U.S. Patent No. 6,270,796 and AlleRx™ Dose Pack

Cornerstone BioPharma (“Cornerstone”) of Cary, North Carolina, and J-Med Pharmaceuticals (“J-Med”) of Boston, Massachusetts, today announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd., (“Sovereign”) of Fort Worth, Texas, in connection with U.S. Patent No. 6,270,796 (“the ‘796 patent”). The litigation was brought by the patent owner J-Med and licensee Cornerstone, who markets and sells the AlleRx™ Dose Pack.

AlleRx™ Dose Pack is one of three respiratory focused brands in the Cornerstone product line. The AlleRx™ Dose Pack is a prescribed AM/PM dosing regimen, available in a 10-day and 30-day supply, indicated for relief of the symptoms of vasomotor rhinitis and allergic rhinitis (runny nose associated with high pollen counts and specific year-round allergens). Over 30 million people in the U.S. have been diagnosed with allergic rhinitis alone.

”Cornerstone is dedicated to the development and commercialization of niche respiratory products that serve both the healthcare professionals and their patients,” said Craig Collard, President and CEO of Cornerstone BioPharma. “We will continue to defend the licensed invention of the AlleRx™ Dose Pack against all infringers,” he added.

As part of the settlement, Sovereign entered into a consent judgment confirming the validity and enforceability of the ‘796 patent. Sovereign will cease manufacturing a product intended to be packaged in violation of the ‘796 patent. Sovereign has further agreed to a permanent injunction and admitted that the products they manufactured infringed the ‘796 patent. Cornerstone and J-Med have agreed to not pursue damages for Sovereign’s past infringement.

“The settlement and consent judgment entered by the Court confirm the validity and enforceability of J-Med’s ‘796 patent. With a substantial patent portfolio, J-Med remains dedicated to providing novel therapies to physicians and patients that significantly improve patient care,” said Allan Weinstein, M.D., President of J-Med Pharmaceuticals.

By agreement, Cornerstone, J-Med and Sovereign will make no further public announcements about the resolution of the litigation beyond these written statements.

About Cornerstone BioPharma

Cornerstone BioPharma, Inc. (cornerstonebiopharma.com), located next to North Carolina’s Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the respiratory arena. Cornerstone is actively engaged in strategic licensing of additional prescription products through acquisitions, strategic partnerships and new product development.

About J-Med

J-Med Pharmaceuticals is a 19-year-old intellectual property pharmaceutical company founded by physicians who invent, develop and patent pharmaceutical products and methods, primarily directed to the treatment of respiratory ailments. J-Med actively licenses its patents and patented technologies, and these patent-protected products are manufactured and sold throughout the United States.

About Sovereign

Sovereign Pharmaceuticals, established 1990, is a privately owned and operated company. Sovereign’s committed team of employees excels in cGMP training and is focused on delivering high quality products in a timely manner. During the past three years Sovereign has upgraded equipment and facilities to meet the demands of its customers. The firm has recently completed a major expansion of its Research and Development Department, moving that department to the state-of-the-art 7,200 square foot facility and employing several scientists and additional support personnel.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: 919 Marketing

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Financial/Legal/Venture articles,
CATCH Visitors via Your Competitors Announcements!


Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mariana McCulley - 919Marketing.com 
919-459-8159 mmcculley[.]919marketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any 919 Marketing securities in any jurisdiction including any other companies listed or named in this release.

Financial/Legal/Venture via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From 919 Marketing / Company Profile


Read Financial/Legal/Venture Most Recent Related Newswires:

Acquisition Assessments Arouse the Interest of TPA Business Owners Looking to Sell
TRA Hires Programmer Analyst to Enhance IT Department
Bosnia, Privatized Krajina Insurance Osiguranje is Nationalized - Investors Start Arbitration
TRA Announces Acquisition of Retirement Planning, Inc.
Lexis Advance Wins SIIA Business Technology CODiE Award
FTI Consulting Launches Specialist Director Support Services in the Cayman Islands
LexisNexis Spotlights New Innovations, Analytics & A.I. Offerings at AALL 2017
LexisNexis Digital Library Announces New Agreement with ALM
TRA Hires Tiffany Hanks as Regional Sales Consultant
LexisNexis® Expands Media Intelligence Portfolio with LexisNexis® Media Contacts Solution
LexisNexis Wins 21 Awards from Two Prestigious Publications
Frost & Sullivan Commends AutoGravity for Transforming Automotive Financing Industry
NYSE Governance Services and FTI Consulting Announce 17th Annual Corporate Law Firms Rankings
FTI Consulting and Asia Group Advisors Formalise Affiliate Relationship Across Asia Pacific
LexisNexis Receives 2017 Corporate Leadership Award from Freedom House for Activism in Advancing the Rule of Law

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)